Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome

NCT07497776 is registered in ClinicalTrials.gov with National Institute of Kidney Disease and Urology (NIKDU) as lead sponsor.

NCT NCT07497776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07497776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome
Lead sponsor
National Institute of Kidney Disease and Urology (NIKDU)
Phase
Phase 4
Overall status
Completed
Start date
January 27, 2024
Completion date
October 31, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidaemia